Publications by authors named "Gregg Lucksinger"

Claim this Profile
I
Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial.
Mark Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael Levin, Gregg Lucksinger

Hum Vaccin Immunother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.
Nicholas Van Wagoner, Kenneth Fife, Peter A Leone, David I Bernstein, Terri Warren, Gregg Lucksinger

J Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Dan H Barouch, Frank L Tomaka, Frank Wegmann, Daniel J Stieh, Galit Alter, Gregg Lucksinger

Lancet· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults.
Lars Ostergaard, Gregg H Lucksinger, Judith Absalon, Johannes Beeslaar, Joseph Eiden

Vaccine· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.
Lynda Tussey, Cynthia Strout, Matthew Davis, Casey Johnson, Gregg Lucksinger

Open Forum Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis